MicroRNA basis of physiological hypertrophy.
作者信息
Fu Siyi, Zhuo Ran, Yao Mengchao, Zhang Jiawen, Zhou Hanling, Xiao Junjie
机构信息
Regeneration Lab, School of Life Science, Shanghai University Shanghai, China ; Innovative Drug Research Center of Shanghai University Shanghai, China.
出版信息
Front Genet. 2013 Nov 26;4:253. doi: 10.3389/fgene.2013.00253. eCollection 2013.
Abstract
摘要
相似文献
1
MicroRNA basis of physiological hypertrophy.生理性肥大的微小RNA基础。
Front Genet. 2013 Nov 26;4:253. doi: 10.3389/fgene.2013.00253. eCollection 2013.
2
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.通过工程化心脏组织和测序技术解析病理性心肌肥厚的 microRNA 特征。
J Mol Cell Cardiol. 2015 Apr;81:1-9. doi: 10.1016/j.yjmcc.2015.01.008. Epub 2015 Jan 26.
3
Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.miR-155 的缺失可保护心脏免受病理性心肌肥厚的影响。
Circ Res. 2014 May 9;114(10):1585-95. doi: 10.1161/CIRCRESAHA.114.303784. Epub 2014 Mar 21.
4
Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.生理性和病理性心肌肥厚的分子鉴别：实验研究结果与治疗策略。
Pharmacol Ther. 2010 Oct;128(1):191-227. doi: 10.1016/j.pharmthera.2010.04.005. Epub 2010 May 12.
5
Small changes can make a big difference - microRNA regulation of cardiac hypertrophy.微小的变化也能产生巨大的影响——微小 RNA 调控心肌肥厚。
J Mol Cell Cardiol. 2012 Jan;52(1):74-82. doi: 10.1016/j.yjmcc.2011.09.015. Epub 2011 Sep 24.
6
Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.分析 miRNA 特征驱动先天性心脏病绵羊模型适应性右心室肥厚
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H847-H854. doi: 10.1152/ajpheart.00057.2018. Epub 2018 Jun 15.
7
MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.microRNA-19a/b-3p 通过 PDE5A 保护心脏免受高血压引起的病理性心肌肥厚。
J Hypertens. 2018 Sep;36(9):1847-1857. doi: 10.1097/HJH.0000000000001769.
8
MicroRNA and cardiac pathologies.微小RNA与心脏疾病
Physiol Genomics. 2008 Aug 15;34(3):239-42. doi: 10.1152/physiolgenomics.90254.2008. Epub 2008 Jun 10.
9
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.微小RNA-99a的过表达减轻心脏肥大。
PLoS One. 2016 Feb 25;11(2):e0148480. doi: 10.1371/journal.pone.0148480. eCollection 2016.
10
Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.预防射血分数保留型心力衰竭（HFpEF）：在寡核苷酸治疗时代重新审视 microRNA-21 抑制。
Cardiovasc Pathol. 2020 Nov-Dec;49:107243. doi: 10.1016/j.carpath.2020.107243. Epub 2020 May 19.
引用本文的文献
1
Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure.卡维地洛改变心力衰竭患者循环中的miR-1和miR-214。
Pharmgenomics Pers Med. 2020 Sep 3;13:375-383. doi: 10.2147/PGPM.S263740. eCollection 2020.
2
A snapshot of genetic and epigenetic basis of arrhythmia and heart failure.心律失常和心力衰竭的遗传与表观遗传基础概述。
Front Genet. 2015 Mar 3;6:74. doi: 10.3389/fgene.2015.00074. eCollection 2015.
3
Desregulated microRNAs in aging-related heart failure.衰老相关心力衰竭中失调的微小RNA
Front Genet. 2014 Jun 25;5:186. doi: 10.3389/fgene.2014.00186. eCollection 2014.
4
MicroRNAs in diabetic cardiomyopathy and clinical perspectives.糖尿病性心肌病中的微小RNA及临床前景
Front Genet. 2014 Jun 25;5:185. doi: 10.3389/fgene.2014.00185. eCollection 2014.
5
MicroRNA as a novel player in atrial fibrillation.微小RNA作为心房颤动中的一个新角色。
Front Genet. 2014 Apr 30;5:97. doi: 10.3389/fgene.2014.00097. eCollection 2014.
6
Exercise-induced physiological hypertrophy initiates activation of cardiac progenitor cells.运动诱导的生理性肥大引发心脏祖细胞的激活。
Int J Clin Exp Pathol. 2014 Jan 15;7(2):663-9. eCollection 2014.
本文引用的文献
1
Non-coding RNAs in cardiac remodeling and heart failure.非编码 RNA 在心脏重构和心力衰竭中的作用。
Circ Res. 2013 Aug 30;113(6):676-89. doi: 10.1161/CIRCRESAHA.113.300226.
2
MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.甲状腺激素诱导的心肌肥厚中触发的 miRNA-208a 和 miRNA-208b-1 型血管紧张素 II 受体 (AT1R) 对 miRNA-208a/α-MHC 调节的作用。
Mol Cell Endocrinol. 2013 Jul 15;374(1-2):117-24. doi: 10.1016/j.mce.2013.04.010. Epub 2013 Apr 26.
3
Medicine. Cardiac regeneration.医学。心脏再生。
Science. 2012 Dec 21;338(6114):1549-50. doi: 10.1126/science.1228951.
4
Molecular basis of physiological heart growth: fundamental concepts and new players.生理性心脏生长的分子基础：基本概念和新的参与者。
Nat Rev Mol Cell Biol. 2013 Jan;14(1):38-48. doi: 10.1038/nrm3495.
5
The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation.成年心脏通过生理性肥大、心脏干细胞激活和新的心肌细胞形成来应对增加的工作负荷。
Eur Heart J. 2014 Oct 14;35(39):2722-31. doi: 10.1093/eurheartj/ehs338. Epub 2012 Oct 25.
6
MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells.MicroRNA-204 对于人源性心肌祖细胞的分化是必需的。
J Mol Cell Cardiol. 2012 Dec;53(6):751-9. doi: 10.1016/j.yjmcc.2012.08.024. Epub 2012 Sep 7.
7
MicroRNAs in control of cardiac hypertrophy.微小 RNA 在心脏肥大调控中的作用。
Cardiovasc Res. 2012 Mar 15;93(4):563-72. doi: 10.1093/cvr/cvs013. Epub 2012 Jan 19.
8
Circulating microRNAs: novel biomarkers for cardiovascular diseases.循环 microRNAs：心血管疾病的新型生物标志物。
J Mol Med (Berl). 2012 Aug;90(8):865-75. doi: 10.1007/s00109-011-0840-5. Epub 2011 Dec 8.
9
Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms.生理性心脏重塑对耐力运动训练的反应：细胞和分子机制。
Heart. 2012 Jan;98(1):5-10. doi: 10.1136/heartjnl-2011-300639. Epub 2011 Aug 31.
10
MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats.微小 RNA29 参与了有氧运动训练对大鼠心室顺应性改善的作用。
Physiol Genomics. 2011 Jun 15;43(11):665-73. doi: 10.1152/physiolgenomics.00145.2010. Epub 2011 Mar 29.
Zotero 插件